ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 671,34
1,34%
Dow Jones
39 001,51
0,43%
DAX
18 254,18
1,03%
Brent Oil
85,055
0,43%
Bitcoin
64 791,23
-0,29%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Axonics Inc (AXNX)

  7. Axonics Inc (AXNX) Actualités

AXNX Axonics Inc

67,52
0,01 (0,01%)
Dernière mise à jour : 19:05:21
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Axonics Inc AXNX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,01 0,01% 67,52 19:05:21
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
67,41 67,41 67,77 67,51
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/5/202422:01BWAxonics Receives Regulatory Approval for Recharge-Free SNM..
30/4/202422:01BWAxonics Reports First Quarter 2024 Financial Results
24/4/202412:30PRNUSBoston Scientific Announces Results for First Quarter 2024
22/3/202421:01BWAxonics Stockholders Approve Merger Agreement with Boston..
21/3/202421:54BWAxonics Provides Update on Inter Partes Review Proceedings
14/3/202411:00BWAxonics Receives CE Mark Approval for Fourth-Generation..
07/3/202423:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/2/202422:01BWAxonics Responds to ITC Action by Medtronic
28/2/202422:05EDGAR2Form 8-K - Current report
28/2/202422:01BWAxonics Reports Fourth Quarter and Fiscal Year 2023..
22/2/202414:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
03/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202412:30PRNUSBoston Scientific Announces Results for Fourth Quarter and..
11/1/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202421:07PRNUSKuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to..
08/1/202423:19EDGAR2Form DEF 14A - Other definitive proxy statements
08/1/202423:19EDGAR2Form 8-K - Current report
08/1/202422:55PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
08/1/202417:36DJNAxonics Shares Climb 20% After Acquisition by Boston..
08/1/202414:47EDGAR2Form 8-K - Current report
08/1/202413:41DJNBoston Scientific To Acquire Axonics For About $3.7 Billion
08/1/202413:00BWAxonics Reports Preliminary 4Q23 and Fiscal Year 2023..
29/12/202301:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:01BWAxonics to Present at the J.P. Morgan Healthcare Conference
26/12/202319:31EDGAR2Form 144 - Report of proposed sale of securities
06/11/202318:00GLOBERevolutionizing Care: NeuroQure’s Groundbreaking Path to..
01/11/202311:00BWAxonics to Participate in November Investor Conferences
30/10/202321:06EDGAR2Form 8-K - Current report
30/10/202321:01BWAxonics Reports Third Quarter 2023 Financial Results
07/10/202302:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/10/202322:08EDGAR2Form 8-K - Current report
04/10/202301:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202312:00BWAxonics to Report Third Quarter 2023 Financial Results on..
25/8/202312:00BWAxonics to Participate in September Investor Conferences
21/8/202323:59EDGAR2Form 144 - Report of proposed sale of securities
21/8/202323:30EDGAR2Form 8-K - Current report
21/8/202312:00BWAxonics Announces CFO Retirement and Appoints Successor
31/7/202323:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/7/202322:05EDGAR2Form 8-K - Current report
27/7/202322:01BWAxonics Reports Second Quarter 2023 Financial Results
29/6/202312:00BWAxonics to Report Second Quarter 2023 Financial Results on..
29/6/202302:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202302:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
AXNX
Axonics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés